Patient Guide: A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 167 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05104866
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 167 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Los Angeles, California
  • Palo Alto, California
  • • And 164 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily